文献速递外周动脉疾病血液透析通路

Viabahn覆膜支架治疗累及髂外动脉的广泛主髂动脉闭塞病变的混合与腔内修复 outcomes

Outcomes of Hybrid and Endovascular Repair Using Self-Expanding Viabahn Stents in Extensive Aortoiliac Occlusive Disease (TASC II C and D) Involving the External Iliac Artery.
PubMed 文献 · J Endovasc Ther · 2026-06-19

单中心回顾性研究纳入2012至2020年118条肢体,因症状性TASC II C/D级主髂动脉闭塞累及髂外动脉行Viabahn自膨式覆膜支架置入,技术成功率100%,2年二期通畅率95%,小直径支架(<8 mm)与通畅率降低相关,同期股总动脉内膜剥脱术与通畅率提高相关。

要点

  • Viabahn覆膜支架治疗累及髂外动脉的TASC II C/D级病变,2年二期通畅率达95%。
  • 支架直径<8 mm与一期通畅率及免于靶病变血运重建率降低独立相关。
  • 同期股总动脉内膜剥脱术是一期通畅率的独立保护因素,应视为治疗策略必要组成部分。

核心结论

  • Viabahn自膨式覆膜支架治疗累及髂外动脉的广泛主髂动脉病变,围术期并发症可接受,中期二期通畅率高,与主双股动脉旁路术通常报告的结果相似。
  • 同期股总动脉内膜剥脱术是通畅率的主要决定因素,应被视为治疗策略的必要组成部分。
  • 需要额外长期数据评估自膨式覆膜支架在此类病变中的作用。

研究设计与样本

  • 单中心回顾性研究,纳入2012至2020年间所有连续因症状性TASC II C和D级病变在髂外动脉置入Viabahn自膨式覆膜支架的患者。
  • 共118条肢体;病变局限于髂动脉者经皮治疗,病变延伸至股总动脉者采用混合方法。
  • 采用Kaplan-Meier曲线估计通畅率、主要不良肢体事件、靶病变血运重建和保肢率。

主要发现

  • 118条肢体中,48条(41%)因间歇性跛行治疗,33条(28%)因静息痛,37条(31%)因组织缺损。
  • 病变为TASC C级43条(36%),TASC D级75条(64%);慢性完全性髂动脉闭塞26条(22%);合并股总动脉病变97条(82%);所有病变均累及髂外动脉。
  • 技术成功率为100%;围术期主要不良心血管事件6例(5.7%),包括4例(3.8%)死亡;早期主要不良肢体事件11例(7.6%)。
  • 2年一期通畅率、辅助一期通畅率和二期通畅率分别为85%、88%和95%。

临床怎么用

  • 对于累及髂外动脉的TASC II C/D级主髂动脉闭塞,Viabahn覆膜支架可提供可接受的围术期风险和较高的中期二期通畅率。
  • 应积极处理合并的股总动脉病变,同期行股总动脉内膜剥脱术可能改善通畅率。
  • 选择支架时应考虑使用直径≥8 mm的支架,以避免小直径支架带来的通畅率下降。

局限性

  • 本研究为单中心回顾性研究,可能存在选择偏倚。
  • 需要额外长期数据评估自膨式覆膜支架在此类病变中的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe early and midterm outcomes of Viabahn stenting for extensive aortoiliac occlusive disease involving the external iliac artery (EIA). METHODS: In this single-center retrospective study, all consecutive patients in whom a covered self-expanding (SE) Viabahn stent was implanted (W.L. Gore & Associates, Inc, Flagstaff, Arizona) in the EIA for symptomatic Trans-Atlantic Intersociety Consensus (TASC) II C and D lesions between 2012 and 2020 were included. Lesions limited to the iliac artery were treated percutaneously. Iliac lesions extending down to the common femoral artery (CFA) were treated with a hybrid approach. Patency, major adverse limb events (MALEs), target lesion revascularization (TLR), and limb salvage rates were estimated using Kaplan-Meier curves. RESULTS: Of 118 limbs, 48 (41%) were treated for claudication, 33 (28%) for rest pain, and 37 (31%) for tissue loss. Lesions were TASC C (n = 43 limbs, 36%) or TASC D (n = 75 limbs, 64%). Chronic total iliac occlusions were identified in 26 limbs (22%). Concomitant CFA lesions were recorded in 97 limbs (82%). All lesions involved the EIA. Technical success was achieved in 100% of cases. Six (5.7%) perioperative major adverse cardiovascular events occurred, including 4 (3.8%) deaths. Eleven (7.6%) early MALEs were recorded. Two-year primary patency, assisted primary patency, and secondary patency were 85%, 88%, and 95%, respectively. After multivariate analysis, small-diameter stents (<8 mm) were associated with lower primary patency rates (hazard ratio [HR] 3.20, 95% confidence interval [CI]: 1.26-8.13, P = .014) and lower freedom from TLR rates (HR 2.61, 95% CI: 1.02-6.66, P = .045). Adjunctive CFA endarterectomy was significantly associated with higher primary patency rates (HR 0.38, 95% CI: 0.15-0.95, P = .038). CONCLUSION: The use of Viabahn SE covered stents for extensive aortoiliac disease involving the EIA provided acceptable postoperative morbidity and high rates of midterm secondary patency, similar to those usually reported with aortobifemoral bypass. Adjunctive CFA endarterectomy was a major determinant of patency and should be considered an essential component of the treatment strategy. Additional long-term data are necessary to evaluate the role of SE covered stents for the treatment of such lesions.Clinical ImpactThe endovascular management of extensive aortoiliac occlusive disease involving the external iliac artery remains challenging. This study represents one of the largest series dedicated to the treatment of TASC II C and D lesions involving the external iliac artery with self-expanding covered stents. The results suggest mid-term secondary patency rates comparable to those commonly reported after aortobifemoral bypass. Notably, concomitant common femoral bifurcation treatment and the use of ≥8-mm diameter stents were associated with improved patency rates, suggesting that aggressive management of common femoral artery lesions and the use of larger-diameter stents may contribute to optimizing long-term outcomes.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Mercier L, Bosse C, Derycke L, et al. Outcomes of Hybrid and Endovascular Repair Using Self-Expanding Viabahn Stents in Extensive Aortoiliac Occlusive Disease (TASC II C and D) Involving the External Iliac Artery. J Endovasc Ther. 2026. PMID: 42317183. doi:10.1177/15266028261454963

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。